Tennessee · 114th Regular Session (2025-2026) · Bill

HB 502: TennCare - As enacted, authorizes the bureau to provide coverage and treatment on behalf of an enrollee for the diagnosis, including genetic testing, and treatment of Kleefstra syndrome in the same manner and to the same extent that the bureau provides coverage for autism spectrum disorder, Trisomy 21 or Down syndrome, and other similar or related genetic disorders, when determined to be medically necessary. - Amends TCA Title 56 and Title 71.

Enacted Last action April 4, 2025: Pub. Ch. 145

Plain-language summary

HB 502 is a bill introduced in the Tennessee House on January 29, 2025. According to its official title, it concerns: TennCare - As enacted, authorizes the bureau to provide coverage and treatment on behalf of an enrollee for the diagnosis, including genetic testing, and treatment of Kleefstra syndrome in the same manner and to the same extent that the bureau provides coverage for autism spectrum disorder, Trisomy 21 or Down syndrome, and other similar or related genetic disorders, when determined to be medically necessary. - Amends TCA Title 56 and Title 71. Primary sponsor: Mary Littleton (Republican). Most recent recorded action (April 4, 2025): Pub. Ch. 145.

Sponsors

Primary sponsor: Mary Littleton (Republican).